Association of Rare Variants in ARSA with Parkinson's Disease.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
10 2023
Historique:
revised: 25 05 2023
received: 06 03 2023
accepted: 12 06 2023
pmc-release: 01 10 2024
medline: 30 10 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Several lysosomal genes are associated with Parkinson's disease (PD), yet the association between PD and ARSA remains unclear. To study rare ARSA variants in PD. To study rare ARSA variants (minor allele frequency < 0.01) in PD, we performed burden analyses in six independent cohorts with 5801 PD patients and 20,475 controls, followed by a meta-analysis. We found evidence for associations between functional ARSA variants and PD in four cohorts (P ≤ 0.05 in each) and in the meta-analysis (P = 0.042). We also found an association between loss-of-function variants and PD in the United Kingdom Biobank cohort (P = 0.005) and in the meta-analysis (P = 0.049). These results should be interpreted with caution as no association survived multiple comparisons correction. Additionally, we describe two families with potential co-segregation of ARSA p.E382K and PD. Rare functional and loss-of-function ARSA variants may be associated with PD. Further replications in large case-control/familial cohorts are required. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Several lysosomal genes are associated with Parkinson's disease (PD), yet the association between PD and ARSA remains unclear.
OBJECTIVES
To study rare ARSA variants in PD.
METHODS
To study rare ARSA variants (minor allele frequency < 0.01) in PD, we performed burden analyses in six independent cohorts with 5801 PD patients and 20,475 controls, followed by a meta-analysis.
RESULTS
We found evidence for associations between functional ARSA variants and PD in four cohorts (P ≤ 0.05 in each) and in the meta-analysis (P = 0.042). We also found an association between loss-of-function variants and PD in the United Kingdom Biobank cohort (P = 0.005) and in the meta-analysis (P = 0.049). These results should be interpreted with caution as no association survived multiple comparisons correction. Additionally, we describe two families with potential co-segregation of ARSA p.E382K and PD.
CONCLUSIONS
Rare functional and loss-of-function ARSA variants may be associated with PD. Further replications in large case-control/familial cohorts are required. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 37381728
doi: 10.1002/mds.29521
pmc: PMC10615669
mid: NIHMS1914494
doi:

Substances chimiques

Cerebroside-Sulfatase EC 3.1.6.8

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1806-1812

Subventions

Organisme : NINDS NIH HHS
ID : K02 NS080915
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Front Med (Lausanne). 2020 Oct 20;7:576221
pubmed: 33195324
Am J Hum Genet. 2013 Jul 11;93(1):42-53
pubmed: 23768515
Brain. 2023 May 2;146(5):1859-1872
pubmed: 36370000
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Neurobiol Aging. 2022 Jan;109:269-272
pubmed: 34531044
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Neurol Genet. 2020 Jan 09;6(1):385
pubmed: 32042909
Bioinformatics. 2016 May 1;32(9):1423-6
pubmed: 27153000
NPJ Parkinsons Dis. 2016;2:
pubmed: 27110593
Parkinsonism Relat Disord. 2020 Apr;73:60-71
pubmed: 31761667
Acta Neurol Scand. 1994 Mar;89(3):171-4
pubmed: 7913281
Neurobiol Dis. 2018 Apr;112:85-90
pubmed: 29369793
Am J Hum Genet. 2012 Aug 10;91(2):224-37
pubmed: 22863193
BMC Bioinformatics. 2014 May 02;15:125
pubmed: 24884706
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Pediatr Endocrinol Rev. 2016 Jun;13 Suppl 1:689-96
pubmed: 27491217
N Engl J Med. 2009 Oct 22;361(17):1651-61
pubmed: 19846850
Neurology. 1992 Jun;42(6):1142-6
pubmed: 1603339
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Lancet Neurol. 2019 Dec;18(12):1091-1102
pubmed: 31701892
Neurology. 2013 Apr 23;80(17):1606-10
pubmed: 23535491
Mol Med. 2011 Sep-Oct;17(9-10):1107-18
pubmed: 21717034
Sci Rep. 2020 Mar 27;10(1):5567
pubmed: 32221382
Brain. 2019 Sep 1;142(9):2845-2859
pubmed: 31312839
Brain. 2019 Dec 1;142(12):e70
pubmed: 31670782
Mov Disord. 2021 Aug;36(8):1795-1804
pubmed: 33960523
J Parkinsons Dis. 2020;10(1):301-313
pubmed: 31868683
Acta Neuropathol. 2007 Nov;114(5):481-9
pubmed: 17653558
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Brain. 2017 Dec 1;140(12):3191-3203
pubmed: 29140481
Brain. 2020 Jun 1;143(6):e47
pubmed: 32437521
Acta Neuropathol. 2017 Sep;134(3):351-382
pubmed: 28638987
Nat Genet. 2017 Oct;49(10):1511-1516
pubmed: 28892059

Auteurs

Konstantin Senkevich (K)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Mariia Beletskaia (M)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Aliza Dworkind (A)

Department of Physiology, McGill University, Montréal, Quebec, Canada.

Eric Yu (E)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Human Genetics, McGill University, Montréal, Quebec, Canada.

Jamil Ahmad (J)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Jennifer A Ruskey (JA)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Farnaz Asayesh (F)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Human Genetics, McGill University, Montréal, Quebec, Canada.

Dan Spiegelman (D)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.

Stanley Fahn (S)

Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.

Cheryl Waters (C)

Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.

Oury Monchi (O)

Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Department of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, Alberta, Canada.
Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, Alberta, Canada.

Yves Dauvilliers (Y)

National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France.

Nicolas Dupré (N)

Division of Neurosciences, CHU de Québec, Université Laval, Quebec City, Quebec, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec, Quebec, Canada.

Lior Greenbaum (L)

The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel.
The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Sharon Hassin-Baer (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Movement Disorders Institute, Department of Neurology, Sheba Medical Center, Tel Aviv, Israel.

Ilya Nagornov (I)

Research Centre for Medical Genetics, Moscow, Russia.

Alexandr Tyurin (A)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Irina Miliukhina (I)

Institute of the Human Brain of RAS, St. Petersburg, Russia.

Alla Timofeeva (A)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Anton Emelyanov (A)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Jean-François Trempe (JF)

Department of Pharmacology and Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, Quebec, Canada.

Ekaterina Zakharova (E)

Research Centre for Medical Genetics, Moscow, Russia.

Roy N Alcalay (RN)

Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
Division of Movement Disorders, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Sofya Pchelina (S)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Ziv Gan-Or (Z)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Department of Human Genetics, McGill University, Montréal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH